biodivine-lib-param-bn:0.2.1

total uncompressed bytes

25.6 MB

total files

460

Fix

NewInclude { include: [ "src/**/*", "Cargo.*", "LICENSE", "README.md", "!**/*_tests.*", ], has_build_script: false, }

392 wasted files

total waste: 25.3 MB

sbml_models/real_world/[v247]__[r1100]__[ERBB-14-RECEPTOR-SIGNALING]__[cellcollective]/model.sbml : 2.0 MB
sbml_models/real_world/[v351]__[r737]__[NSP14]__[covid-uni-lu]/model.sbml : 1.6 MB
sbml_models/real_world/[v139]__[r557]__[SIGNAL-TRANSDUCTION-IN-FIBROBLASTS]__[cellcollective]/model.sbml : 1.2 MB
sbml_models/real_world/[v131]__[r302]__[INFLUENZA-VIRUS-REPLICATION-CYCLE]__[cellcollective]/model.sbml : 777.0 KB
sbml_models/real_world/[v321]__[r533]__[SIGNALING-IN-MACROPHAGE-ACTIVATION]__[cellcollective]/model.sbml : 694.9 KB
sbml_models/real_world/[v188]__[r351]__[CD4-T-CELL-SIGNALING]__[cellcollective]/model.sbml : 629.7 KB
sbml_models/real_world/[v165]__[r275]__[VIRUS-REPLICATION-CYCLE]__[covid-uni-lu]/model.sbml : 605.8 KB
sbml_models/real_world/[v104]__[r226]__[EGFR-ERBB-SIGNALING]__[cellcollective]/model.sbml : 592.5 KB
sbml_models/real_world/[v118]__[r218]__[IL1-SIGNALING]__[cellcollective]/model.sbml : 590.8 KB
sbml_models/real_world/[v110]__[r212]__[RODRIGUEZ-JORGE-TCR-SIGNALLING-17-07-2018]__[ginsim]/model.sbml : 495.9 KB
sbml_models/real_world/[v101]__[r158]__[T-CELL-RECEPTOR-SIGNALING]__[cellcollective]/model.sbml : 436.1 KB
sbml_models/real_world/[v205]__[r269]__[ER-STRESS]__[covid-uni-lu]/model.sbml : 407.2 KB
sbml_models/real_world/[v260]__[r258]__[NSP9-PROTEIN]__[covid-uni-lu]/model.sbml : 399.7 KB
sbml_models/real_world/[v86]__[r149]__[IL6-SIGNALING]__[cellcollective]/model.sbml : 396.0 KB
sbml_models/real_world/[v49]__[r167]__[STOMATAL-OPENING]__[cellcollective]/model.sbml : 389.4 KB
sbml_models/real_world/[v60]__[r195]__[TLGL-SURVIVAL-NETWORK-2011]__[cellcollective]/model.sbml : 367.0 KB
sbml_models/real_world/[v193]__[r328]__[KYNURENINE-PATHWAY]__[covid-uni-lu]/model.sbml : 362.7 KB
sbml_models/real_world/[v61]__[r193]__[TLGL-SURVIVAL-NETWORK-2008]__[cellcollective]/model.sbml : 328.3 KB
sbml_models/real_world/[v120]__[r195]__[COAGULATION-PATHWAY]__[covid-uni-lu]/model.sbml : 307.4 KB
sbml_models/hmox1_pathway.sbml : 290.7 KB
sbml_models/real_world/[v168]__[r243]__[HMOX1-PATHWAY]__[covid-uni-lu]/model.sbml : 289.8 KB
sbml_models/real_world/[v68]__[r103]__[HGF-SIGNALING-IN-KERATINOCYTES]__[cellcollective]/model.sbml : 276.0 KB
sbml_models/real_world/[v73]__[r114]__[YEAST-APOPTOSIS]__[cellcollective]/model.sbml : 271.1 KB
sbml_models/real_world/[v73]__[r97]__[GLUCOSE-REPRESSION-SIGNALING-2009]__[cellcollective]/model.sbml : 268.7 KB
sbml_models/real_world/[v81]__[r160]__[LIMPHOPOIESIS-REGULATORY-NETWORK]__[cellcollective]/model.sbml : 255.6 KB
sbml_models/real_world/[v70]__[r153]__[COLITISASSOCIATE-COLON-CANCER]__[cellcollective]/model.sbml : 234.2 KB
sbml_models/real_world/[v50]__[r97]__[DIFFERENTIATION-OF-T-LYMPHOCYTES]__[cellcollective]/model.sbml : 226.0 KB
sbml_models/real_world/[v44]__[r78]__[GUARD-CELL-ABSCISIC-ACID-SIGNALING]__[cellcollective]/model.sbml : 221.0 KB
sbml_models/real_world/[v67]__[r131]__[BORTEZOMIB-RESPONSES-IN-U266]__[cellcollective]/model.sbml : 213.2 KB
sbml_models/real_world/[v53]__[r135]__[B-BRONCHISEPTICA-AND-T-RETORTAEFORMIS]__[cellcollective]/model.sbml : 211.6 KB
sbml_models/real_world/[v85]__[r130]__[RENIN-ANGIOTENSIN]__[covid-uni-lu]/model.sbml : 210.1 KB
sbml_models/real_world/[v38]__[r96]__[CD4-T-CELL-DIFFERENTIATION-6678]__[cellcollective]/model.sbml : 210.0 KB
sbml_models/real_world/[v53]__[r104]__[MAPK-LARGE-19-06-2013]__[ginsim]/model.sbml : 203.6 KB
sbml_models/real_world/[v104]__[r166]__[ETC]__[covid-uni-lu]/model.sbml : 197.8 KB
sbml_models/cell_collective_vut.sbml : 187.9 KB
sbml_models/real_world/[v66]__[r139]__[SIGNALING-PATHWAY-FOR-BUTHANOL-PRODUCTION]__[cellcollective]/model.sbml : 187.9 KB
sbml_models/real_world/[v102]__[r157]__[INTERFERON-1]__[covid-uni-lu]/model.sbml : 186.5 KB
sbml_models/real_world/[v94]__[r132]__[PYRIMIDINE-DEPRIVATION]__[covid-uni-lu]/model.sbml : 183.6 KB
sbml_models/real_world/[v41]__[r73]__[APOPTOSIS-NETWORK]__[cellcollective]/model.sbml : 183.6 KB
sbml_models/apoptosis_network.sbml : 183.6 KB
sbml_models/real_world/[v28]__[r123]__[FA-BRCA-PATHWAY]__[cellcollective]/model.sbml : 176.7 KB
sbml_models/real_world/[v62]__[r108]__[PC12-CELL-DIFFERENTIATION]__[cellcollective]/model.sbml : 176.7 KB
sbml_models/real_world/[v32]__[r156]__[TUMOR-CELL-INVASION-AND-MIGRATION]__[cellcollective]/model.sbml : 176.2 KB
sbml_models/real_world/[v34]__[r43]__[CHOLESTEROL-REGULATORY-PATHWAY]__[cellcollective]/model.sbml : 161.8 KB
sbml_models/real_world/[v40]__[r53]__[T-CELL-SIGNALING]__[cellcollective]/model.sbml : 161.0 KB
sbml_models/real_world/[v53]__[r104]__[MAPK-CANCER-CELL-FATE]__[cellcollective]/model.sbml : 159.9 KB
sbml_models/real_world/[v60]__[r193]__[T-LGL]__[ginsim]/model.sbml : 155.7 KB
sbml_models/real_world/[v25]__[r81]__[SKBR3-BREAST-CELL-LINE-LONGTERM]__[cellcollective]/model.sbml : 155.4 KB
sbml_models/real_world/[v91]__[r104]__[PAMP-SIGNALING]__[covid-uni-lu]/model.sbml : 144.4 KB
sbml_models/real_world/[v25]__[r70]__[HCC1954-BREAST-CELL-LINE-LONGTERM]__[cellcollective]/model.sbml : 144.3 KB
sbml_models/real_world/[v51]__[r96]__[SENESCENCE-ASSOCIATED-SECRETORY-PHENOTYPE]__[cellcollective]/model.sbml : 139.3 KB
sbml_models/real_world/[v66]__[r128]__[IMMUNE-CHECKPOINT-NETWORK]__[DOI-10.3390-cancers12123600]/model.sbml : 135.2 KB
sbml_models/real_world/[v17]__[r78]__[MAPK-RED1-19-06-2013]__[ginsim]/model.sbml : 134.9 KB
sbml_models/real_world/[v28]__[r45]__[DEATH-RECEPTOR-SIGNALING]__[cellcollective]/model.sbml : 131.6 KB
sbml_models/real_world/[v25]__[r70]__[BT474-BREAST-CELL-LINE-LONGTERM]__[cellcollective]/model.sbml : 128.5 KB
sbml_models/real_world/[v14]__[r66]__[ARABIDOPSIS-THALIANA-CELL-CYCLE]__[cellcollective]/model.sbml : 128.1 KB
sbml_models/real_world/[v33]__[r94]__[LYMPHOID-AND-MYELOID-CELL-SPECIFICATION]__[cellcollective]/model.sbml : 127.7 KB
sbml_models/real_world/[v33]__[r79]__[BORDETELLA-BRONCHISEPTICA]__[cellcollective]/model.sbml : 125.6 KB
sbml_models/real_world/[v18]__[r59]__[BUDDING-YEAST-CELL-CYCLE]__[cellcollective]/model.sbml : 108.9 KB
sbml_models/real_world/[v26]__[r81]__[PROINFLAMMATORY-TUMOR-MICROENVIRONMENT]__[cellcollective]/model.sbml : 107.0 KB
sbml_models/real_world/[v20]__[r51]__[MAMMALIAN-CELL-CYCLE-1607]__[cellcollective]/model.sbml : 106.6 KB
sbml_models/real_world/[v42]__[r51]__[TREATMENT-OF-PROSTATE-CANCER]__[cellcollective]/model.sbml : 104.0 KB
sbml_models/real_world/[v24]__[r48]__[TOL-REGULATORY-NETWORK]__[cellcollective]/model.sbml : 101.6 KB
sbml_models/real_world/[v60]__[r62]__[NSP4-NSP6]__[covid-uni-lu]/model.sbml : 101.2 KB
sbml_models/real_world/[v16]__[r46]__[HCC1954-BREAST-CELL-LINE]__[cellcollective]/model.sbml : 98.7 KB
sbml_models/real_world/[v19]__[r79]__[HUMAN-GONADAL-SEX-DETERMINATION]__[cellcollective]/model.sbml : 96.6 KB
sbml_models/real_world/[v26]__[r58]__[TRICHOSTRONGYLUS-RETORTAEFORMIS]__[cellcollective]/model.sbml : 96.5 KB
sbml_models/real_world/[v31]__[r50]__[SEPARATION-INITIATION-NETWORK]__[cellcollective]/model.sbml : 96.1 KB
sbml_models/real_world/[v52]__[r92]__[ORF10-CUL2-PATHWAY]__[covid-uni-lu]/model.sbml : 95.2 KB
sbml_models/real_world/[v29]__[r128]__[BLOOD-STEM-CELL-NETWORK]__[biomodels]/model.sbml : 93.7 KB
sbml_models/real_world/[v18]__[r78]__[CD4-T-CELL-DIFFERENTIATION]__[cellcollective]/model.sbml : 91.4 KB
sbml_models/real_world/[v16]__[r41]__[SKBR3-BREAST-CELL-LINE]__[cellcollective]/model.sbml : 90.8 KB
sbml_models/real_world/[v33]__[r52]__[CELL-FATE-MULTISCALE]__[ginsim]/model.sbml : 87.2 KB
sbml_models/real_world/[v16]__[r46]__[BT474-BREAST-CELL-LINE]__[cellcollective]/model.sbml : 85.8 KB
sbml_models/real_world/[v26]__[r79]__[HSPC-MSC-0]__[ginsim]/model.sbml : 85.7 KB
sbml_models/real_world/[v20]__[r88]__[SUPP-MAT-MOD-NET]__[ginsim]/model.sbml : 83.3 KB
sbml_models/real_world/[v23]__[r24]__[FGF-PATHWAY-OF-DROSOPHILA]__[cellcollective]/model.sbml : 82.2 KB
sbml_models/real_world/[v16]__[r58]__[MAPK-RED3-19-06-2013]__[ginsim]/model.sbml : 81.5 KB
sbml_models/real_world/[v24]__[r32]__[HH-PATHWAY-OF-DROSOPHILA]__[cellcollective]/model.sbml : 81.0 KB
sbml_models/real_world/[v47]__[r49]__[ORF3A]__[covid-uni-lu]/model.sbml : 80.3 KB
sbml_models/real_world/[v28]__[r45]__[CALZONE-CELL-FATE]__[ginsim]/model.sbml : 80.3 KB
sbml_models/real_world/[v24]__[r32]__[HH-PATHWAY-11-06-2013]__[ginsim]/model.sbml : 79.9 KB
sbml_models/real_world/[v26]__[r29]__[WG-PATHWAY-OF-DROSOPHILA]__[cellcollective]/model.sbml : 79.7 KB
sbml_models/real_world/[v19]__[r32]__[OXIDATIVE-STRESS-PATHWAY]__[cellcollective]/model.sbml : 79.0 KB
sbml_models/real_world/[v15]__[r66]__[FANCONI-ANEMIA-AND-CHECKPOINT-RECOVERY]__[cellcollective]/model.sbml : 78.6 KB
sbml_models/real_world/[v24]__[r28]__[PROCESSING-OF-SPZ-NETWORK-FROM-DROSOPHILA]__[cellcollective]/model.sbml : 77.9 KB
sbml_models/apoptosis_stable.sbml : 76.9 KB
sbml_models/real_world/[v351]__[r737]__[NSP14]__[covid-uni-lu]/model.aeon : 74.6 KB
sbml_models/real_world/[v10]__[r35]__[MAMMALIAN-CELL-CYCLE]__[cellcollective]/model.sbml : 70.5 KB
sbml_models/real_world/[v15]__[r38]__[CARDIAC-DEVELOPMENT]__[cellcollective]/model.sbml : 68.4 KB
sbml_models/real_world/[v23]__[r43]__[AURORA-KINASE-A-IN-NEUROBLASTOMA]__[cellcollective]/model.sbml : 67.8 KB
sbml_models/real_world/[v16]__[r22]__[NEUROTRANSMITTER-SIGNALING-PATHWAY]__[cellcollective]/model.sbml : 67.0 KB
sbml_models/real_world/[v26]__[r28]__[WG-PATHWAY-11-06-2013]__[ginsim]/model.sbml : 66.1 KB
sbml_models/real_world/[v24]__[r28]__[SPZ-PROCESSING-12-06-2013]__[ginsim]/model.sbml : 64.7 KB
sbml_models/real_world/[v18]__[r43]__[TLGL-SURVIVAL-NETWORK]__[cellcollective]/model.sbml : 64.6 KB
sbml_models/real_world/[v40]__[r57]__[TCR-SIG-40]__[ginsim]/model.sbml : 63.1 KB
sbml_models/real_world/[v48]__[r52]__[IFN-LAMBDA]__[covid-uni-lu]/model.sbml : 62.8 KB
sbml_models/real_world/[v22]__[r39]__[B-CELL-DIFFERENTIATION]__[cellcollective]/model.sbml : 62.7 KB
sbml_models/real_world/[v18]__[r18]__[VEGF-PATHWAY-OF-DROSOPHILA]__[cellcollective]/model.sbml : 62.7 KB
sbml_models/real_world/[v23]__[r24]__[FGF-PATHWAY-12-06-2013]__[ginsim]/model.sbml : 62.5 KB
sbml_models/real_world/[v18]__[r60]__[MAPK-RED2-12-06-2013]__[ginsim]/model.sbml : 62.0 KB
sbml_models/real_world/[v25]__[r67]__[S-PHASE-ENTRY-SIGNALLING-PATHWAY]__[biomodels]/model.sbml : 58.6 KB
sbml_models/real_world/[v17]__[r29]__[DROSOPHILA-BODY-SEGMENTATION]__[cellcollective]/model.sbml : 57.0 KB
sbml_models/real_world/[v15]__[r38]__[PREDICTING-VARIABLES-IN-CARDIAC-GENE]__[cellcollective]/model.sbml : 55.0 KB
sbml_models/real_world/[v34]__[r40]__[RTC-AND-TRANSCRIPTION]__[covid-uni-lu]/model.sbml : 54.7 KB
sbml_models/real_world/[v23]__[r34]__[T-CELL-DIFFERENTIATION]__[cellcollective]/model.sbml : 54.5 KB
sbml_models/real_world/[v18]__[r58]__[BUDDING-YEAST-IRONS-2009]__[ginsim]/model.sbml : 54.2 KB
sbml_models/real_world/[v18]__[r83]__[T-CD4-LYMPHOCYTE-TRANSCRIPTION]__[biomodels]/model.sbml : 50.6 KB
sbml_models/real_world/[v19]__[r73]__[INFLAMMATORY-RESPONSES]__[biomodels]/model.sbml : 50.4 KB
sbml_models/real_world/[v12]__[r30]__[METABOLIC-INTERACTIONS-IN-THE-GUT-MICROBIOME]__[cellcollective]/model.sbml : 50.4 KB
sbml_models/real_world/[v18]__[r18]__[VEGF-PATHWAY-12-06-2013]__[ginsim]/model.sbml : 49.7 KB
sbml_models/real_world/[v247]__[r1100]__[ERBB-14-RECEPTOR-SIGNALING]__[cellcollective]/model.aeon : 48.9 KB
sbml_models/real_world/[v38]__[r38]__[E-PROTEIN]__[covid-uni-lu]/model.sbml : 48.3 KB
sbml_models/real_world/[v31]__[r36]__[APOPTOSIS]__[covid-uni-lu]/model.sbml : 45.2 KB
sbml_models/real_world/[v9]__[r19]__[CELL-CYCLE-TRANSCRIPTION]__[cellcollective]/model.sbml : 44.9 KB
sbml_models/real_world/[v20]__[r48]__[ERB-B2]__[ginsim]/model.sbml : 42.9 KB
sbml_models/real_world/[v11]__[r11]__[TOLL-PATHWAY-OF-DROSOPHILA]__[cellcollective]/model.sbml : 35.7 KB
sbml_models/real_world/[v13]__[r22]__[LAC-OPERON]__[cellcollective]/model.sbml : 35.6 KB
sbml_models/real_world/[v11]__[r11]__[TOLL-PATHWAY-12-06-2013]__[ginsim]/model.sbml : 33.2 KB
sbml_models/real_world/[v10]__[r34]__[BOOLEAN-CELL-CYCLE]__[ginsim]/model.sbml : 33.0 KB
sbml_models/real_world/[v5]__[r14]__[CORTICAL-AREA-DEVELOPMENT]__[cellcollective]/model.sbml : 32.0 KB
sbml_models/real_world/[v165]__[r275]__[VIRUS-REPLICATION-CYCLE]__[covid-uni-lu]/model.aeon : 31.9 KB
sbml_models/real_world/[v19]__[r21]__[JNK-PATHWAY]__[covid-uni-lu]/model.sbml : 31.5 KB
sbml_models/real_world/[v13]__[r18]__[REGULATION-OF-THE-LARABINOSE-OPERON]__[cellcollective]/model.sbml : 31.2 KB
aeon_models/hmox_pathway.aeon : 30.8 KB
sbml_models/real_world/[v193]__[r328]__[KYNURENINE-PATHWAY]__[covid-uni-lu]/model.aeon : 30.4 KB
sbml_models/real_world/[v10]__[r27]__[FISSION-YEAST-DAVIDICH-2008]__[ginsim]/model.sbml : 29.0 KB
sbml_models/real_world/[v321]__[r533]__[SIGNALING-IN-MACROPHAGE-ACTIVATION]__[cellcollective]/model.aeon : 29.0 KB
sbml_models/real_world/[v205]__[r269]__[ER-STRESS]__[covid-uni-lu]/model.aeon : 25.8 KB
sbml_models/real_world/[v21]__[r24]__[TGFB-pathway]__[covid-uni-lu]/model.sbml : 25.2 KB
sbml_models/real_world/[v168]__[r243]__[HMOX1-PATHWAY]__[covid-uni-lu]/model.aeon : 22.8 KB
sbml_models/real_world/[v6]__[r11]__[ZEBRA-MIR9-22-07-2011]__[ginsim]/model.sbml : 19.8 KB
sbml_models/real_world/[v139]__[r557]__[SIGNAL-TRANSDUCTION-IN-FIBROBLASTS]__[cellcollective]/model.aeon : 18.9 KB
sbml_models/real_world/[v9]__[r19]__[BUDDING-YEAST-ORLANDO-2008]__[ginsim]/model.sbml : 18.9 KB
sbml_models/real_world/[v10]__[r18]__[ROOT-STEM-CELL-NICHE]__[biomodels]/model.sbml : 16.9 KB
sbml_models/real_world/[v104]__[r166]__[ETC]__[covid-uni-lu]/model.aeon : 16.8 KB
sbml_models/real_world/[v10]__[r14]__[AP-1-ELSE-0-WT]__[ginsim]/model.sbml : 16.7 KB
sbml_models/real_world/[v260]__[r258]__[NSP9-PROTEIN]__[covid-uni-lu]/model.aeon : 15.1 KB
sbml_models/real_world/[v131]__[r302]__[INFLUENZA-VIRUS-REPLICATION-CYCLE]__[cellcollective]/model.aeon : 14.8 KB
sbml_models/real_world/[v9]__[r12]__[G2B]__[ginsim]/model.sbml : 14.3 KB
sbml_models/real_world/[v120]__[r195]__[COAGULATION-PATHWAY]__[covid-uni-lu]/model.aeon : 13.4 KB
sbml_models/real_world/[v94]__[r132]__[PYRIMIDINE-DEPRIVATION]__[covid-uni-lu]/model.aeon : 13.3 KB
sbml_models/real_world/[v85]__[r130]__[RENIN-ANGIOTENSIN]__[covid-uni-lu]/model.aeon : 12.4 KB
sbml_models/real_world/[v34]__[r40]__[RTC-AND-TRANSCRIPTION]__[covid-uni-lu]/model.aeon : 12.2 KB
sbml_models/g2a.sbml : 11.9 KB
sbml_models/real_world/[v5]__[r15]__[G2A]__[ginsim]/model.sbml : 11.8 KB
sbml_models/g2a_with_names.sbml : 11.7 KB
sbml_models/real_world/[v188]__[r351]__[CD4-T-CELL-SIGNALING]__[cellcollective]/model.aeon : 10.2 KB
sbml_models/real_world/[v110]__[r212]__[RODRIGUEZ-JORGE-TCR-SIGNALLING-17-07-2018]__[ginsim]/model.aeon : 10.1 KB
sbml_models/real_world/[v49]__[r167]__[STOMATAL-OPENING]__[cellcollective]/model.aeon : 9.7 KB
sbml_models/real_world/[v102]__[r157]__[INTERFERON-1]__[covid-uni-lu]/model.aeon : 9.2 KB
sbml_models/real_world/[v52]__[r92]__[ORF10-CUL2-PATHWAY]__[covid-uni-lu]/model.aeon : 9.1 KB
sbml_models/real_world/[v17]__[r78]__[MAPK-RED1-19-06-2013]__[ginsim]/model.aeon : 8.4 KB
sbml_models/real_world/[v104]__[r226]__[EGFR-ERBB-SIGNALING]__[cellcollective]/model.aeon : 7.7 KB
sbml_models/real_world/[v91]__[r104]__[PAMP-SIGNALING]__[covid-uni-lu]/model.aeon : 7.3 KB
sbml_models/real_world/[v118]__[r218]__[IL1-SIGNALING]__[cellcollective]/model.aeon : 7.2 KB
sbml_models/real_world/[v60]__[r193]__[T-LGL]__[ginsim]/model.aeon : 7.1 KB
sbml_models/real_world/[v60]__[r195]__[TLGL-SURVIVAL-NETWORK-2011]__[cellcollective]/model.aeon : 5.9 KB
sbml_models/real_world/[v61]__[r193]__[TLGL-SURVIVAL-NETWORK-2008]__[cellcollective]/model.aeon : 5.9 KB
sbml_models/real_world/[v53]__[r135]__[B-BRONCHISEPTICA-AND-T-RETORTAEFORMIS]__[cellcollective]/model.aeon : 5.7 KB
sbml_models/real_world/[v66]__[r128]__[IMMUNE-CHECKPOINT-NETWORK]__[DOI-10.3390-cancers12123600]/model.aeon : 5.5 KB
sbml_models/real_world/[v66]__[r139]__[SIGNALING-PATHWAY-FOR-BUTHANOL-PRODUCTION]__[cellcollective]/model.aeon : 5.4 KB
sbml_models/real_world/[v86]__[r149]__[IL6-SIGNALING]__[cellcollective]/model.aeon : 5.2 KB
sbml_models/real_world/[v20]__[r88]__[SUPP-MAT-MOD-NET]__[ginsim]/model.aeon : 4.8 KB
sbml_models/real_world/[v16]__[r58]__[MAPK-RED3-19-06-2013]__[ginsim]/model.aeon : 4.8 KB
sbml_models/real_world/[v73]__[r114]__[YEAST-APOPTOSIS]__[cellcollective]/model.aeon : 4.7 KB
sbml_models/real_world/[v26]__[r79]__[HSPC-MSC-0]__[ginsim]/model.aeon : 4.7 KB
sbml_models/real_world/[v32]__[r156]__[TUMOR-CELL-INVASION-AND-MIGRATION]__[cellcollective]/model.aeon : 4.6 KB
sbml_models/real_world/[v81]__[r160]__[LIMPHOPOIESIS-REGULATORY-NETWORK]__[cellcollective]/model.aeon : 4.5 KB
sbml_models/real_world/[v60]__[r62]__[NSP4-NSP6]__[covid-uni-lu]/model.aeon : 4.5 KB
sbml_models/real_world/[v48]__[r52]__[IFN-LAMBDA]__[covid-uni-lu]/model.aeon : 4.3 KB
sbml_models/real_world/[v29]__[r128]__[BLOOD-STEM-CELL-NETWORK]__[biomodels]/model.aeon : 4.3 KB
sbml_models/real_world/[v101]__[r158]__[T-CELL-RECEPTOR-SIGNALING]__[cellcollective]/model.aeon : 4.2 KB
sbml_models/real_world/[v70]__[r153]__[COLITISASSOCIATE-COLON-CANCER]__[cellcollective]/model.aeon : 3.8 KB
sbml_models/real_world/[v53]__[r104]__[MAPK-LARGE-19-06-2013]__[ginsim]/model.aeon : 3.6 KB
.github/workflows/build.yml : 3.4 KB
sbml_models/real_world/[v28]__[r123]__[FA-BRCA-PATHWAY]__[cellcollective]/model.aeon : 3.4 KB
sbml_models/real_world/[v47]__[r49]__[ORF3A]__[covid-uni-lu]/model.aeon : 3.3 KB
sbml_models/real_world/[v33]__[r94]__[LYMPHOID-AND-MYELOID-CELL-SPECIFICATION]__[cellcollective]/model.aeon : 3.3 KB
sbml_models/real_world/[v67]__[r131]__[BORTEZOMIB-RESPONSES-IN-U266]__[cellcollective]/model.aeon : 3.3 KB
sbml_models/real_world/[v18]__[r60]__[MAPK-RED2-12-06-2013]__[ginsim]/model.aeon : 3.1 KB
sbml_models/real_world/[v14]__[r66]__[ARABIDOPSIS-THALIANA-CELL-CYCLE]__[cellcollective]/model.aeon : 3.0 KB
sbml_models/real_world/[v81]__[r160]__[LIMPHOPOIESIS-REGULATORY-NETWORK]__[cellcollective]/model.txt : 3.0 KB
sbml_models/real_world/[v53]__[r104]__[MAPK-CANCER-CELL-FATE]__[cellcollective]/model.aeon : 2.9 KB
sbml_models/real_world/[v34]__[r43]__[CHOLESTEROL-REGULATORY-PATHWAY]__[cellcollective]/model.aeon : 2.9 KB
sbml_models/real_world/[v26]__[r81]__[PROINFLAMMATORY-TUMOR-MICROENVIRONMENT]__[cellcollective]/model.aeon : 2.8 KB
sbml_models/real_world/[v73]__[r97]__[GLUCOSE-REPRESSION-SIGNALING-2009]__[cellcollective]/model.aeon : 2.8 KB
sbml_models/real_world/[v24]__[r28]__[SPZ-PROCESSING-12-06-2013]__[ginsim]/model.aeon : 2.7 KB
sbml_models/real_world/[v25]__[r81]__[SKBR3-BREAST-CELL-LINE-LONGTERM]__[cellcollective]/model.aeon : 2.6 KB
sbml_models/real_world/[v50]__[r97]__[DIFFERENTIATION-OF-T-LYMPHOCYTES]__[cellcollective]/model.aeon : 2.6 KB
sbml_models/real_world/[v68]__[r103]__[HGF-SIGNALING-IN-KERATINOCYTES]__[cellcollective]/model.aeon : 2.6 KB
sbml_models/real_world/[v38]__[r38]__[E-PROTEIN]__[covid-uni-lu]/model.aeon : 2.6 KB
sbml_models/real_world/[v38]__[r96]__[CD4-T-CELL-DIFFERENTIATION-6678]__[cellcollective]/model.aeon : 2.6 KB
sbml_models/real_world/[v18]__[r58]__[BUDDING-YEAST-IRONS-2009]__[ginsim]/model.aeon : 2.6 KB
sbml_models/real_world/[v62]__[r108]__[PC12-CELL-DIFFERENTIATION]__[cellcollective]/model.aeon : 2.5 KB
docs-head.html : 2.4 KB
sbml_models/real_world/[v19]__[r79]__[HUMAN-GONADAL-SEX-DETERMINATION]__[cellcollective]/model.aeon : 2.4 KB
sbml_models/real_world/[v51]__[r96]__[SENESCENCE-ASSOCIATED-SECRETORY-PHENOTYPE]__[cellcollective]/model.aeon : 2.3 KB
sbml_models/real_world/[v44]__[r78]__[GUARD-CELL-ABSCISIC-ACID-SIGNALING]__[cellcollective]/model.aeon : 2.3 KB
sbml_models/real_world/[v247]__[r1100]__[ERBB-14-RECEPTOR-SIGNALING]__[cellcollective]/model.txt : 2.2 KB
sbml_models/real_world/[v25]__[r70]__[HCC1954-BREAST-CELL-LINE-LONGTERM]__[cellcollective]/model.aeon : 2.2 KB
sbml_models/real_world/[v25]__[r70]__[BT474-BREAST-CELL-LINE-LONGTERM]__[cellcollective]/model.aeon : 2.2 KB
sbml_models/real_world/[v18]__[r78]__[CD4-T-CELL-DIFFERENTIATION]__[cellcollective]/model.aeon : 2.1 KB
sbml_models/real_world/[v25]__[r67]__[S-PHASE-ENTRY-SIGNALLING-PATHWAY]__[biomodels]/model.aeon : 2.1 KB
sbml_models/real_world/[v24]__[r32]__[HH-PATHWAY-11-06-2013]__[ginsim]/model.aeon : 2.0 KB
sbml_models/real_world/[v33]__[r94]__[LYMPHOID-AND-MYELOID-CELL-SPECIFICATION]__[cellcollective]/model.txt : 1.9 KB
sbml_models/real_world/[v18]__[r83]__[T-CD4-LYMPHOCYTE-TRANSCRIPTION]__[biomodels]/model.aeon : 1.9 KB
sbml_models/real_world/[v12]__[r30]__[METABOLIC-INTERACTIONS-IN-THE-GUT-MICROBIOME]__[cellcollective]/model.aeon : 1.9 KB
sbml_models/real_world/[v15]__[r66]__[FANCONI-ANEMIA-AND-CHECKPOINT-RECOVERY]__[cellcollective]/model.aeon : 1.9 KB
sbml_models/real_world/[v41]__[r73]__[APOPTOSIS-NETWORK]__[cellcollective]/model.aeon : 1.8 KB
sbml_models/real_world/[v33]__[r79]__[BORDETELLA-BRONCHISEPTICA]__[cellcollective]/model.aeon : 1.8 KB
sbml_models/real_world/[v19]__[r73]__[INFLAMMATORY-RESPONSES]__[biomodels]/model.aeon : 1.8 KB
sbml_models/real_world/[v23]__[r24]__[FGF-PATHWAY-12-06-2013]__[ginsim]/model.aeon : 1.8 KB
sbml_models/real_world/[v23]__[r43]__[AURORA-KINASE-A-IN-NEUROBLASTOMA]__[cellcollective]/model.aeon : 1.7 KB
sbml_models/real_world/[v19]__[r21]__[JNK-PATHWAY]__[covid-uni-lu]/model.aeon : 1.7 KB
sbml_models/real_world/[v139]__[r557]__[SIGNAL-TRANSDUCTION-IN-FIBROBLASTS]__[cellcollective]/model.txt : 1.7 KB
sbml_models/real_world/[v40]__[r57]__[TCR-SIG-40]__[ginsim]/model.aeon : 1.6 KB
sbml_models/real_world/[v42]__[r51]__[TREATMENT-OF-PROSTATE-CANCER]__[cellcollective]/model.aeon : 1.6 KB
sbml_models/real_world/[v20]__[r48]__[ERB-B2]__[ginsim]/model.aeon : 1.6 KB
sbml_models/real_world/[v31]__[r36]__[APOPTOSIS]__[covid-uni-lu]/model.aeon : 1.6 KB
sbml_models/real_world/[v18]__[r18]__[VEGF-PATHWAY-12-06-2013]__[ginsim]/model.aeon : 1.6 KB
sbml_models/real_world/[v33]__[r52]__[CELL-FATE-MULTISCALE]__[ginsim]/model.aeon : 1.6 KB
sbml_models/real_world/[v26]__[r28]__[WG-PATHWAY-11-06-2013]__[ginsim]/model.aeon : 1.5 KB
sbml_models/real_world/[v16]__[r46]__[HCC1954-BREAST-CELL-LINE]__[cellcollective]/model.aeon : 1.5 KB
sbml_models/real_world/[v16]__[r46]__[BT474-BREAST-CELL-LINE]__[cellcollective]/model.aeon : 1.4 KB
sbml_models/real_world/[v15]__[r38]__[PREDICTING-VARIABLES-IN-CARDIAC-GENE]__[cellcollective]/model.aeon : 1.4 KB
sbml_models/real_world/[v10]__[r27]__[FISSION-YEAST-DAVIDICH-2008]__[ginsim]/model.aeon : 1.4 KB
sbml_models/real_world/[v18]__[r59]__[BUDDING-YEAST-CELL-CYCLE]__[cellcollective]/model.aeon : 1.4 KB
sbml_models/real_world/[v40]__[r53]__[T-CELL-SIGNALING]__[cellcollective]/model.aeon : 1.4 KB
sbml_models/real_world/[v15]__[r38]__[CARDIAC-DEVELOPMENT]__[cellcollective]/model.aeon : 1.4 KB
sbml_models/real_world/[v31]__[r50]__[SEPARATION-INITIATION-NETWORK]__[cellcollective]/model.aeon : 1.4 KB
sbml_models/real_world/[v18]__[r43]__[TLGL-SURVIVAL-NETWORK]__[cellcollective]/model.aeon : 1.4 KB
sbml_models/real_world/[v10]__[r34]__[BOOLEAN-CELL-CYCLE]__[ginsim]/model.aeon : 1.4 KB
sbml_models/real_world/[v24]__[r48]__[TOL-REGULATORY-NETWORK]__[cellcollective]/model.aeon : 1.3 KB
sbml_models/real_world/[v16]__[r22]__[NEUROTRANSMITTER-SIGNALING-PATHWAY]__[cellcollective]/model.aeon : 1.3 KB
sbml_models/real_world/[v28]__[r45]__[CALZONE-CELL-FATE]__[ginsim]/model.aeon : 1.3 KB
sbml_models/real_world/[v20]__[r51]__[MAMMALIAN-CELL-CYCLE-1607]__[cellcollective]/model.aeon : 1.3 KB
sbml_models/real_world/[v26]__[r58]__[TRICHOSTRONGYLUS-RETORTAEFORMIS]__[cellcollective]/model.aeon : 1.3 KB
src/bin/gen_diff_tests.rs : 1.3 KB
sbml_models/real_world/[v28]__[r45]__[DEATH-RECEPTOR-SIGNALING]__[cellcollective]/model.aeon : 1.3 KB
sbml_models/real_world/[v21]__[r24]__[TGFB-pathway]__[covid-uni-lu]/model.aeon : 1.2 KB
sbml_models/real_world/[v22]__[r39]__[B-CELL-DIFFERENTIATION]__[cellcollective]/model.aeon : 1.2 KB
sbml_models/real_world/[v165]__[r275]__[VIRUS-REPLICATION-CYCLE]__[covid-uni-lu]/model.txt : 1.2 KB
sbml_models/real_world/[v16]__[r41]__[SKBR3-BREAST-CELL-LINE]__[cellcollective]/model.aeon : 1.2 KB
sbml_models/real_world/[v10]__[r35]__[MAMMALIAN-CELL-CYCLE]__[cellcollective]/model.aeon : 1.1 KB
sbml_models/real_world/[v17]__[r29]__[DROSOPHILA-BODY-SEGMENTATION]__[cellcollective]/model.aeon : 952 B
sbml_models/real_world/[v23]__[r34]__[T-CELL-DIFFERENTIATION]__[cellcollective]/model.aeon : 926 B
sbml_models/real_world/[v321]__[r533]__[SIGNALING-IN-MACROPHAGE-ACTIVATION]__[cellcollective]/model.txt : 925 B
Makefile.toml : 902 B
sbml_models/real_world/[v24]__[r28]__[PROCESSING-OF-SPZ-NETWORK-FROM-DROSOPHILA]__[cellcollective]/model.aeon : 798 B
sbml_models/real_world/[v19]__[r32]__[OXIDATIVE-STRESS-PATHWAY]__[cellcollective]/model.aeon : 778 B
sbml_models/real_world/[v24]__[r32]__[HH-PATHWAY-OF-DROSOPHILA]__[cellcollective]/model.aeon : 731 B
sbml_models/real_world/[v19]__[r79]__[HUMAN-GONADAL-SEX-DETERMINATION]__[cellcollective]/model.txt : 676 B
sbml_models/real_world/[v26]__[r29]__[WG-PATHWAY-OF-DROSOPHILA]__[cellcollective]/model.aeon : 654 B
sbml_models/real_world/[v188]__[r351]__[CD4-T-CELL-SIGNALING]__[cellcollective]/model.txt : 612 B
aeon_models/g2a_instantiated.aeon : 612 B
aeon_models/g2a_p9.aeon : 581 B
sbml_models/real_world/[v23]__[r24]__[FGF-PATHWAY-OF-DROSOPHILA]__[cellcollective]/model.aeon : 574 B
sbml_models/real_world/[v9]__[r19]__[BUDDING-YEAST-ORLANDO-2008]__[ginsim]/model.aeon : 528 B
aeon_models/g2a_p1026.aeon : 511 B
sbml_models/real_world/[v24]__[r32]__[HH-PATHWAY-OF-DROSOPHILA]__[cellcollective]/model.txt : 509 B
sbml_models/real_world/[v131]__[r302]__[INFLUENZA-VIRUS-REPLICATION-CYCLE]__[cellcollective]/model.txt : 489 B
sbml_models/real_world/[v66]__[r139]__[SIGNALING-PATHWAY-FOR-BUTHANOL-PRODUCTION]__[cellcollective]/model.txt : 460 B
sbml_models/real_world/[v31]__[r50]__[SEPARATION-INITIATION-NETWORK]__[cellcollective]/model.txt : 446 B
sbml_models/real_world/[v6]__[r11]__[ZEBRA-MIR9-22-07-2011]__[ginsim]/model.aeon : 443 B
sbml_models/real_world/[v9]__[r19]__[CELL-CYCLE-TRANSCRIPTION]__[cellcollective]/model.aeon : 436 B
sbml_models/real_world/[v28]__[r123]__[FA-BRCA-PATHWAY]__[cellcollective]/model.txt : 420 B
sbml_models/real_world/[v11]__[r11]__[TOLL-PATHWAY-12-06-2013]__[ginsim]/model.aeon : 413 B
sbml_models/real_world/[v10]__[r18]__[ROOT-STEM-CELL-NICHE]__[biomodels]/model.aeon : 404 B
sbml_models/real_world/[v67]__[r131]__[BORTEZOMIB-RESPONSES-IN-U266]__[cellcollective]/model.txt : 392 B
sbml_models/real_world/[v73]__[r97]__[GLUCOSE-REPRESSION-SIGNALING-2009]__[cellcollective]/model.txt : 390 B
sbml_models/real_world/[v18]__[r18]__[VEGF-PATHWAY-OF-DROSOPHILA]__[cellcollective]/model.aeon : 388 B
sbml_models/real_world/[v5]__[r15]__[G2A]__[ginsim]/model.aeon : 383 B
sbml_models/real_world/[v38]__[r96]__[CD4-T-CELL-DIFFERENTIATION-6678]__[cellcollective]/model.txt : 374 B
sbml_models/real_world/[v13]__[r18]__[REGULATION-OF-THE-LARABINOSE-OPERON]__[cellcollective]/model.aeon : 366 B
sbml_models/real_world/[v5]__[r14]__[CORTICAL-AREA-DEVELOPMENT]__[cellcollective]/model.aeon : 363 B
.gitignore : 355 B
sbml_models/real_world/[v26]__[r29]__[WG-PATHWAY-OF-DROSOPHILA]__[cellcollective]/model.txt : 342 B
sbml_models/real_world/[v13]__[r22]__[LAC-OPERON]__[cellcollective]/model.aeon : 340 B
sbml_models/real_world/[v49]__[r167]__[STOMATAL-OPENING]__[cellcollective]/model.txt : 337 B
sbml_models/real_world/[v10]__[r14]__[AP-1-ELSE-0-WT]__[ginsim]/model.aeon : 336 B
sbml_models/real_world/[v14]__[r66]__[ARABIDOPSIS-THALIANA-CELL-CYCLE]__[cellcollective]/model.txt : 333 B
sbml_models/real_world/[v9]__[r12]__[G2B]__[ginsim]/model.aeon : 324 B
sbml_models/real_world/[v15]__[r66]__[FANCONI-ANEMIA-AND-CHECKPOINT-RECOVERY]__[cellcollective]/model.txt : 319 B
sbml_models/real_world/[v66]__[r128]__[IMMUNE-CHECKPOINT-NETWORK]__[DOI-10.3390-cancers12123600]/model.txt : 307 B
sbml_models/real_world/[v351]__[r737]__[NSP14]__[covid-uni-lu]/model.txt : 303 B
sbml_models/real_world/[v11]__[r11]__[TOLL-PATHWAY-OF-DROSOPHILA]__[cellcollective]/model.aeon : 302 B
sbml_models/real_world/[v104]__[r166]__[ETC]__[covid-uni-lu]/model.txt : 268 B
sbml_models/real_world/[v23]__[r43]__[AURORA-KINASE-A-IN-NEUROBLASTOMA]__[cellcollective]/model.txt : 240 B
sbml_models/real_world/[v48]__[r52]__[IFN-LAMBDA]__[covid-uni-lu]/model.txt : 227 B
sbml_models/real_world/[v44]__[r78]__[GUARD-CELL-ABSCISIC-ACID-SIGNALING]__[cellcollective]/model.txt : 216 B
sbml_models/real_world/[v10]__[r35]__[MAMMALIAN-CELL-CYCLE]__[cellcollective]/model.txt : 213 B
sbml_models/real_world/[v91]__[r104]__[PAMP-SIGNALING]__[covid-uni-lu]/model.txt : 212 B
sbml_models/real_world/[v120]__[r195]__[COAGULATION-PATHWAY]__[covid-uni-lu]/model.txt : 208 B
sbml_models/real_world/[v104]__[r226]__[EGFR-ERBB-SIGNALING]__[cellcollective]/model.txt : 204 B
sbml_models/real_world/[v23]__[r24]__[FGF-PATHWAY-OF-DROSOPHILA]__[cellcollective]/model.txt : 202 B
sbml_models/real_world/[v47]__[r49]__[ORF3A]__[covid-uni-lu]/model.txt : 193 B
sbml_models/real_world/[v52]__[r92]__[ORF10-CUL2-PATHWAY]__[covid-uni-lu]/model.txt : 190 B
sbml_models/real_world/[v42]__[r51]__[TREATMENT-OF-PROSTATE-CANCER]__[cellcollective]/model.txt : 186 B
sbml_models/real_world/[v11]__[r11]__[TOLL-PATHWAY-OF-DROSOPHILA]__[cellcollective]/model.txt : 178 B
sbml_models/real_world/[v51]__[r96]__[SENESCENCE-ASSOCIATED-SECRETORY-PHENOTYPE]__[cellcollective]/model.txt : 173 B
sbml_models/real_world/[v168]__[r243]__[HMOX1-PATHWAY]__[covid-uni-lu]/model.txt : 169 B
sbml_models/real_world/[v13]__[r18]__[REGULATION-OF-THE-LARABINOSE-OPERON]__[cellcollective]/model.txt : 169 B
sbml_models/real_world/[v70]__[r153]__[COLITISASSOCIATE-COLON-CANCER]__[cellcollective]/model.txt : 167 B
sbml_models/real_world/[v26]__[r58]__[TRICHOSTRONGYLUS-RETORTAEFORMIS]__[cellcollective]/model.txt : 159 B
sbml_models/real_world/[v22]__[r39]__[B-CELL-DIFFERENTIATION]__[cellcollective]/model.txt : 153 B
sbml_models/real_world/[v118]__[r218]__[IL1-SIGNALING]__[cellcollective]/model.txt : 150 B
sbml_models/real_world/[v86]__[r149]__[IL6-SIGNALING]__[cellcollective]/model.txt : 148 B
sbml_models/real_world/[v41]__[r73]__[APOPTOSIS-NETWORK]__[cellcollective]/model.txt : 148 B
sbml_models/real_world/[v18]__[r59]__[BUDDING-YEAST-CELL-CYCLE]__[cellcollective]/model.txt : 147 B
sbml_models/real_world/[v40]__[r53]__[T-CELL-SIGNALING]__[cellcollective]/model.txt : 144 B
sbml_models/real_world/[v20]__[r51]__[MAMMALIAN-CELL-CYCLE-1607]__[cellcollective]/model.txt : 138 B
.githooks/pre-commit : 138 B
sbml_models/real_world/[v26]__[r81]__[PROINFLAMMATORY-TUMOR-MICROENVIRONMENT]__[cellcollective]/model.txt : 131 B
sbml_models/real_world/[v94]__[r132]__[PYRIMIDINE-DEPRIVATION]__[covid-uni-lu]/model.txt : 129 B
sbml_models/real_world/[v34]__[r40]__[RTC-AND-TRANSCRIPTION]__[covid-uni-lu]/model.txt : 128 B
sbml_models/real_world/[v193]__[r328]__[KYNURENINE-PATHWAY]__[covid-uni-lu]/model.txt : 125 B
sbml_models/real_world/[v9]__[r19]__[CELL-CYCLE-TRANSCRIPTION]__[cellcollective]/model.txt : 124 B
sbml_models/real_world/[v85]__[r130]__[RENIN-ANGIOTENSIN]__[covid-uni-lu]/model.txt : 124 B
sbml_models/real_world/[v24]__[r28]__[PROCESSING-OF-SPZ-NETWORK-FROM-DROSOPHILA]__[cellcollective]/model.txt : 124 B
sbml_models/real_world/[v260]__[r258]__[NSP9-PROTEIN]__[covid-uni-lu]/model.txt : 119 B
sbml_models/real_world/[v21]__[r24]__[TGFB-pathway]__[covid-uni-lu]/model.txt : 119 B
sbml_models/real_world/[v19]__[r21]__[JNK-PATHWAY]__[covid-uni-lu]/model.txt : 118 B
sbml_models/real_world/[v102]__[r157]__[INTERFERON-1]__[covid-uni-lu]/model.txt : 118 B
sbml_models/real_world/[v60]__[r62]__[NSP4-NSP6]__[covid-uni-lu]/model.txt : 116 B
sbml_models/real_world/[v38]__[r38]__[E-PROTEIN]__[covid-uni-lu]/model.txt : 116 B
sbml_models/real_world/[v31]__[r36]__[APOPTOSIS]__[covid-uni-lu]/model.txt : 116 B
sbml_models/real_world/[v205]__[r269]__[ER-STRESS]__[covid-uni-lu]/model.txt : 116 B
sbml_models/real_world/[v53]__[r135]__[B-BRONCHISEPTICA-AND-T-RETORTAEFORMIS]__[cellcollective]/model.txt : 110 B
sbml_models/real_world/[v16]__[r46]__[HCC1954-BREAST-CELL-LINE]__[cellcollective]/model.txt : 108 B
sbml_models/real_world/[v25]__[r70]__[HCC1954-BREAST-CELL-LINE-LONGTERM]__[cellcollective]/model.txt : 107 B
sbml_models/real_world/[v16]__[r46]__[BT474-BREAST-CELL-LINE]__[cellcollective]/model.txt : 106 B
sbml_models/real_world/[v16]__[r41]__[SKBR3-BREAST-CELL-LINE]__[cellcollective]/model.txt : 106 B
sbml_models/real_world/[v25]__[r81]__[SKBR3-BREAST-CELL-LINE-LONGTERM]__[cellcollective]/model.txt : 105 B
sbml_models/real_world/[v25]__[r70]__[BT474-BREAST-CELL-LINE-LONGTERM]__[cellcollective]/model.txt : 105 B
sbml_models/real_world/[v18]__[r18]__[VEGF-PATHWAY-OF-DROSOPHILA]__[cellcollective]/model.txt : 105 B
sbml_models/real_world/[v12]__[r30]__[METABOLIC-INTERACTIONS-IN-THE-GUT-MICROBIOME]__[cellcollective]/model.txt : 105 B
sbml_models/real_world/[v18]__[r43]__[TLGL-SURVIVAL-NETWORK]__[cellcollective]/model.txt : 103 B
sbml_models/real_world/[v18]__[r78]__[CD4-T-CELL-DIFFERENTIATION]__[cellcollective]/model.txt : 102 B
sbml_models/real_world/[v15]__[r38]__[PREDICTING-VARIABLES-IN-CARDIAC-GENE]__[cellcollective]/model.txt : 101 B
sbml_models/real_world/[v25]__[r67]__[S-PHASE-ENTRY-SIGNALLING-PATHWAY]__[biomodels]/model.txt : 98 B
sbml_models/real_world/[v17]__[r29]__[DROSOPHILA-BODY-SEGMENTATION]__[cellcollective]/model.txt : 97 B
sbml_models/real_world/[v32]__[r156]__[TUMOR-CELL-INVASION-AND-MIGRATION]__[cellcollective]/model.txt : 95 B
sbml_models/real_world/[v16]__[r22]__[NEUROTRANSMITTER-SIGNALING-PATHWAY]__[cellcollective]/model.txt : 95 B
sbml_models/real_world/[v50]__[r97]__[DIFFERENTIATION-OF-T-LYMPHOCYTES]__[cellcollective]/model.txt : 93 B
sbml_models/real_world/[v68]__[r103]__[HGF-SIGNALING-IN-KERATINOCYTES]__[cellcollective]/model.txt : 91 B
sbml_models/real_world/[v34]__[r43]__[CHOLESTEROL-REGULATORY-PATHWAY]__[cellcollective]/model.txt : 91 B
sbml_models/real_world/[v53]__[r104]__[MAPK-CANCER-CELL-FATE]__[cellcollective]/model.txt : 90 B
sbml_models/real_world/[v61]__[r193]__[TLGL-SURVIVAL-NETWORK-2008]__[cellcollective]/model.txt : 87 B
sbml_models/real_world/[v60]__[r195]__[TLGL-SURVIVAL-NETWORK-2011]__[cellcollective]/model.txt : 87 B
sbml_models/real_world/[v62]__[r108]__[PC12-CELL-DIFFERENTIATION]__[cellcollective]/model.txt : 86 B
sbml_models/real_world/[v5]__[r14]__[CORTICAL-AREA-DEVELOPMENT]__[cellcollective]/model.txt : 86 B
sbml_models/real_world/[v33]__[r79]__[BORDETELLA-BRONCHISEPTICA]__[cellcollective]/model.txt : 86 B
sbml_models/real_world/[v101]__[r158]__[T-CELL-RECEPTOR-SIGNALING]__[cellcollective]/model.txt : 86 B
sbml_models/real_world/[v28]__[r45]__[DEATH-RECEPTOR-SIGNALING]__[cellcollective]/model.txt : 85 B
sbml_models/real_world/[v19]__[r32]__[OXIDATIVE-STRESS-PATHWAY]__[cellcollective]/model.txt : 85 B
sbml_models/real_world/[v24]__[r48]__[TOL-REGULATORY-NETWORK]__[cellcollective]/model.txt : 83 B
sbml_models/real_world/[v23]__[r34]__[T-CELL-DIFFERENTIATION]__[cellcollective]/model.txt : 83 B
sbml_models/real_world/[v15]__[r38]__[CARDIAC-DEVELOPMENT]__[cellcollective]/model.txt : 80 B
sbml_models/real_world/[v73]__[r114]__[YEAST-APOPTOSIS]__[cellcollective]/model.txt : 76 B
sbml_models/real_world/[v13]__[r22]__[LAC-OPERON]__[cellcollective]/model.txt : 71 B
.githooks/README.txt : 70 B
sbml_models/real_world/[v10]__[r14]__[AP-1-ELSE-0-WT]__[ginsim]/model.txt : 54 B
sbml_models/real_world/[v29]__[r128]__[BLOOD-STEM-CELL-NETWORK]__[biomodels]/model.txt : 47 B
sbml_models/real_world/[v19]__[r73]__[INFLAMMATORY-RESPONSES]__[biomodels]/model.txt : 47 B
sbml_models/real_world/[v18]__[r83]__[T-CD4-LYMPHOCYTE-TRANSCRIPTION]__[biomodels]/model.txt : 47 B
sbml_models/real_world/[v10]__[r18]__[ROOT-STEM-CELL-NICHE]__[biomodels]/model.txt : 47 B
sbml_models/real_world/[v9]__[r12]__[G2B]__[ginsim]/model.txt : 36 B
sbml_models/real_world/[v5]__[r15]__[G2A]__[ginsim]/model.txt : 36 B
sbml_models/real_world/[v26]__[r79]__[HSPC-MSC-0]__[ginsim]/model.txt : 32 B
sbml_models/real_world/[v6]__[r11]__[ZEBRA-MIR9-22-07-2011]__[ginsim]/model.txt : 26 B
sbml_models/real_world/[v53]__[r104]__[MAPK-LARGE-19-06-2013]__[ginsim]/model.txt : 26 B
sbml_models/real_world/[v33]__[r52]__[CELL-FATE-MULTISCALE]__[ginsim]/model.txt : 26 B
sbml_models/real_world/[v28]__[r45]__[CALZONE-CELL-FATE]__[ginsim]/model.txt : 26 B
sbml_models/real_world/[v24]__[r32]__[HH-PATHWAY-11-06-2013]__[ginsim]/model.txt : 26 B
sbml_models/real_world/[v24]__[r28]__[SPZ-PROCESSING-12-06-2013]__[ginsim]/model.txt : 26 B
sbml_models/real_world/[v23]__[r24]__[FGF-PATHWAY-12-06-2013]__[ginsim]/model.txt : 26 B
sbml_models/real_world/[v20]__[r88]__[SUPP-MAT-MOD-NET]__[ginsim]/model.txt : 26 B
sbml_models/real_world/[v18]__[r60]__[MAPK-RED2-12-06-2013]__[ginsim]/model.txt : 26 B
sbml_models/real_world/[v18]__[r18]__[VEGF-PATHWAY-12-06-2013]__[ginsim]/model.txt : 26 B
sbml_models/real_world/[v17]__[r78]__[MAPK-RED1-19-06-2013]__[ginsim]/model.txt : 26 B
sbml_models/real_world/[v16]__[r58]__[MAPK-RED3-19-06-2013]__[ginsim]/model.txt : 26 B
sbml_models/real_world/[v11]__[r11]__[TOLL-PATHWAY-12-06-2013]__[ginsim]/model.txt : 26 B
sbml_models/real_world/[v110]__[r212]__[RODRIGUEZ-JORGE-TCR-SIGNALLING-17-07-2018]__[ginsim]/model.txt : 26 B
sbml_models/real_world/[v9]__[r19]__[BUDDING-YEAST-ORLANDO-2008]__[ginsim]/model.txt : 25 B
sbml_models/real_world/[v60]__[r193]__[T-LGL]__[ginsim]/model.txt : 25 B
sbml_models/real_world/[v40]__[r57]__[TCR-SIG-40]__[ginsim]/model.txt : 25 B
sbml_models/real_world/[v26]__[r28]__[WG-PATHWAY-11-06-2013]__[ginsim]/model.txt : 25 B
sbml_models/real_world/[v20]__[r48]__[ERB-B2]__[ginsim]/model.txt : 25 B
sbml_models/real_world/[v18]__[r58]__[BUDDING-YEAST-IRONS-2009]__[ginsim]/model.txt : 25 B
sbml_models/real_world/[v10]__[r27]__[FISSION-YEAST-DAVIDICH-2008]__[ginsim]/model.txt : 25 B
sbml_models/real_world/[v10]__[r34]__[BOOLEAN-CELL-CYCLE]__[ginsim]/model.txt : 24 B